Icon

PARSABIV (nda208325)- (2.5MG/0.5ML (2.5MG/0.5ML),5MG/ML (5MG/ML),10MG/2ML (5MG/ML))

ETELCALCETIDE KAI PHARMS INC
2.5MG/0.5ML (2.5MG/0.5ML),5MG/ML (5MG/ML),10MG/2ML (5MG/ML)
Yes No
2034-Jun-27 2022-Feb-07
None None
None No
PARSABIV is a calcium-sensing receptor agonist indicated for: • Secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis.
0 2 0
Total Other Developers 6
Drugs with Suitability No
2.5MG/0.5ML (2.5MG/0.5ML) ** ** - - -
5MG/ML (5MG/ML) ** ** - - -
10MG/2ML (5MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.